Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 5/2005

Content (11 Articles)

Review

Immunotherapy for superficial bladder cancer

Ellen A. M. Schenk-Braat, Chris H. Bangma

Original Article

Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn

Ella Kagan, Govind Ragupathi, San San Yi, Celso A. Reis, Jeff Gildersleeve, Daniel Kahne, Henrik Clausen, Samuel J. Danishefsky, Philip O. Livingston

Original Article

Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

Sonja Offner, Armin Hekele, Ulrike Teichmann, Susanne Weinberger, Susanne Gross, Peter Kufer, Christian Itin, Patrick A. Baeuerle, Birgit Kohleisen

Original Article

Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-β

Zheng-Cai Jia, Li-Yun Zou, Bing Ni, Ying Wan, Wei Zhou, Yan-Bo Lv, Miao Geng, Yu-Zhang Wu

Original Article

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

Ralf G. Meyer, Cedrik M. Britten, Ulrike Siepmann, Barbara Petzold, Tolga A. Sagban, Hans A. Lehr, Bernd Weigle, Marc Schmitz, Luis Mateo, Burkhard Schmidt, Helga Bernhard, Thilo Jakob, Rüdiger Hein, Gerold Schuler, Beatrice Schuler-Thurner, Stephan N. Wagner, Ingo Drexler, Gerd Sutter, Nathaly Arndtz, Paul Chaplin, Jost Metz, Alexander Enk, Christoph Huber, Thomas Wölfel

Original Article

Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production

Makoto Kubo, Takashi Morisaki, Kotaro Matsumoto, Akira Tasaki, Naoki Yamanaka, Hiroshi Nakashima, Hideo Kuroki, Katsuya Nakamura, Masafumi Nakamura, Mitsuo Katano

Original Article

Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

Mary E. Dominiecki, Gregory L. Beatty, Zhen-Kun Pan, Paul Neeson, Yvonne Paterson

Original Article

Induction of specific human primary immune responses to a Semliki Forest virus–based tumor vaccine in a Trimera mouse model

Bing Ni, Wenda Gao, Bo Zhu, Zhihua Lin, Zhengcai Jia, Wei Zhou, Jianping Zhao, Li Wang, Yuzhang Wu

Short Communication

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment

Philipp Schütt, Ulrike Buttkereit, Dieter Brandhorst, Monika Lindemann, Sven Schmiedl, Hans Grosse-Wilde, Siegfried Seeber, Mohammad Resa Nowrousian, Bertram Opalka, Thomas Moritz

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine